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It is generally agreed that hippocampal acetylcholine (ACh) is synthesized and released
exclusively from the terminals of the long-axon afferents whose cell bodies reside in
the medial septum and diagonal band. The search for intrinsic cholinergic neurons
in the hippocampus has a long history; however evidence for the existence of these
neurons has been inconsistent, with most investigators failing to detect them using in
situ hybridization or immunohistochemical staining of the cholinergic markers, choline
acetyltransferase (ChAT) or vesicular acetylcholine transporter (VAChT). Advances in
the use of bacterial artificial chromosome (BAC) transgenic mice expressing a reporter
protein under the control of the genomic elements of the Chat gene (Chat-BAC
mice) have facilitated studies of cholinergic neurons. Such mice show robust and
faithful expression of the reporter proteins in all known cholinergic cell populations.
The availability of the Chat-BAC mice re-ignited interest in hippocampal cholinergic
interneurons, because a small number of such reporter-expressing cells is frequently
observed in the hippocampus of these mice. However, to date, attempts to confirm
that these neurons co-express the endogenous cholinergic marker ChAT, or release
ACh, have been unsuccessful. Without such confirmatory evidence it is best to conclude
that there are no cholinergic neurons in the hippocampus. Similar considerations apply
to other BAC transgenic lines, whose utility as a discovery tool for cell populations
heretofore not known to express the genes of interest encoded by the BACs, must
be validated by methods that detect expression of the endogenous genes.
Keywords: acetylcholine, choline acetyltransferase ChAT, vesicular acetylcholine transporter, hippocampus,
transgenic mouse models, basal forebrain cholinergic neurons, septum, slc18a3
The hippocampus continues to fascinate neuroscientists as a brain region essential for encoding
and retrieval of memory [e.g., (Bird and Burgess, 2008; Augustinack et al., 2014)]. One of the
key components of the neuronal circuitry necessary for these processes is the innervation of
the hippocampus by basal forebrain cholinergic neurons (BFCN), which provides modulatory
input mediated by the neurotransmitter, acetylcholine (ACh; Teles-Grilo Ruivo and Mellor,
2013). A decline in BFCN function and diminished cholinergic marker expression is apparent
in aged humans and animals (Sarter and Bruno, 2004; Gauthier et al., 2006; Haense et al.,
2012), in patients with Alzheimer’s disease (AD; Whitehouse et al., 1982; Bowen et al., 1983;
Mufson et al., 2008; Grothe et al., 2012) and in animal models of AD (Savonenko et al., 2005;
Payette et al., 2007; Perez et al., 2007; Goto et al., 2008; Mufson et al., 2008; Machová et al.,
2010; Nikolajsen et al., 2011; Burke et al., 2013; Mellott et al., 2014). Thus, it has been postulated
that abnormal cholinergic neurotransmission, due to dysfunction and/or degeneration of BFCN,
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contributes to the memory deficits seen in advanced age and
in AD (Mufson et al., 2008; Grothe et al., 2012; Haense et al.,
2012). Moreover, unlike the cerebral cortex, the hippocampus
is characterized by a life-long capacity for neurogenesis that is
essential for its normal function (Lee et al., 2012; Aimone et al.,
2014), and age-related slowing of neurogenesis contributes to
cognitive decline (Lee et al., 2012; Samson and Barnes, 2013;
Aimone et al., 2014; Gray and Barnes, 2015). Studies in rats and
mice indicate that cholinergic projections to the dentate gyrus
promote adult hippocampal neurogenesis (Cooper-Kuhn et al.,
2004; Mohapel et al., 2005; Van der Borght et al., 2005; Fontana
et al., 2006; Kaneko et al., 2006; Kotani et al., 2006, 2008; Aztiria
et al., 2007; Zhao et al., 2008; Fréchette et al., 2009; Ho et al.,
2009; Narimatsu et al., 2009; Van Kampen and Eckman, 2010;
Itou et al., 2011; Rennie et al., 2011). Therefore, investigations
of cholinergic mechanisms in the hippocampus are motivated by
both basic science- and translational objectives.
It is generally agreed that hippocampal ACh is produced
and released exclusively by the terminals of BFCN. However,
several studies performed in rodents have suggested the existence
of a minor pool of intrinsic cholinergic neurons in the
hippocampus. The support for this notion is based entirely on
the immunohistochemical localization, within a small number of
hippocampal cell bodies, of the enzyme choline acetyltransferase
(ChAT) that catalyzes the synthesis of ACh and serves as
the sine qua non marker of cholinergic neurons. As yet, no
consensus on the existence of intrinsic hippocampal cholinergic
neurons based on this method has been reached, because
of studies that failed to show ChAT-positive neurons in the
hippocampus (Armstrong et al., 1983; Ichikawa and Hirata,
1986), and because data on the distribution and morphology
of the ChAT-positive hippocampal cells have been inconsistent
(Clarke, 1985; Wainer et al., 1985; Frotscher et al., 1986;
Matthews et al., 1987; Blaker et al., 1988; Kanaya-Ida and Ben
Ari, 1989). Moreover, in situ hybridization failed to detect
Chat mRNA-positive neurons in the hippocampus (Oh et al.,
1992; Lauterborn et al., 1993). Once synthesized by ChAT,
ACh is transported to the synaptic vesicles in a process
catalyzed by the vesicular acetylcholine transporter (VAChT),
encoded by the gene Slc18a3. The Chat and the Slc18a3
genes co-localize within the genome, forming the cholinergic
gene locus (Eiden, 1998; for certain Chat transcripts, Slc18a3
may even be considered as one of their introns) and are
co-expressed (Berse and Blusztajn, 1995). Therefore, VAChT
constitutes another specific marker of cholinergic neurons.
However, no studies that examined the immunohistochemical
(Gilmor et al., 1996, 1998; Roghani et al., 1998; Schäfer
et al., 1998) or in situ hybridization (Roghani et al., 1996;
Ichikawa et al., 1997) localization of VAChT found cellular
staining in the hippocampus. Likewise, direct comparison of
in situ hybridization and immunohistochemical staining for
ChAT and VAChT failed to detect positive cellular staining
in the hippocampus (Ichikawa et al., 1997). Taken together,
the available data based on immunohistochemical and in situ
hybridization methods indicate that the presence of intrinsic
cholinergic neurons in the hippocampus of mice and rats is
unlikely.
In recent years, the availability of transgenic mice engineered
for easy visualization of cholinergic neurons by the expression
of indicator (e.g., fluorescent) proteins under the control of
genomic elements surrounding the cholinergic gene locus,
has generated a renewed interest in the intrinsic hippocampal
cholinergic neurons because, in many cases hippocampal
fluorescent protein-expressing cells have been observed. The
general strategy for the construction of this type of transgenic
mice, pioneered, perfected, and popularized by the GENSAT
project (Gong et al., 2003, 2007; Heintz, 2004), relies on the
use of bacterial artificial chromosomes (BACs) large enough
to contain the entire cholinergic gene locus and surrounding
genomic sequences thought to permit the locus expression
exclusively in cholinergic cells. The BACs are first modified to
encode a fluorescent protein (e.g., EGFP) or Cre recombinase,
and are then used to generate transgenic mouse lines. Note,
that depending on the BAC used, these types of transgenic
mice may express additional genes that are present in the
BAC together with the gene of interest (so-called ‘‘passenger’’
genes; Ting and Feng, 2014). Many of the Chat-BAC mice
have the Chat gene disrupted by the fluorescent protein- or
Cre-encoding gene but must be considered as transgenic for
Slc18a3/VAChT (Tallini et al., 2006; von Engelhardt et al.,
2007; Grybko et al., 2011; Zhao et al., 2011), unless this gene
has been purposefully inactivated (Ting and Feng, 2014).
The overexpression of VAChT in some of these mouse lines
is reportedly associated with novel phenotypes (Nagy and
Aubert, 2012, 2013, 2015; Kolisnyk et al., 2013; Crittenden
et al., 2014). The Chat-BAC mouse lines show excellent and
faithful transgene reporter expression in cholinergic cells, i.e.,
fluorescent proteins mark the appropriate neuronal populations
(e.g., motor neurons, interneurons in the striatum, projection
neurons of the medial habenula, and BFCN) and have the
appropriate phenotypes including the expression of endogenous
Chat as visualized by immunostaining. Thus, it is clear that
studies of these neuronal populations provide information about
the function and properties of bona fide cholinergic neurons.
In our hands, one of these lines (B6.Cg-Tg(RP23-268L19-
EGFP)2Mik/J; Tallini et al., 2006) has permitted studies on
BFCN purified by fluorescence-activated cell sorting (Schnitzler
et al., 2008, 2010) and on the effects of growth factors on
BFCN in culture (Schnitzler et al., 2010) as well as in vivo in
transgenic mouse models of AD (Burke et al., 2013; Mellott
et al., 2014). Unfortunately, transgene reporter expression in
Chat-BAC mouse lines is sometimes seen in brain regions not
known for the presence of cholinergic neurons, such as the
hippocampus. Figure 1 shows an example from this laboratory.
We used the B6.Cg-Tg(RP23-268L19-EGFP)2Mik/J mice
and examined ChAT-immunofluorescence and native EGFP
fluorescence by confocal microscopy in brain sections. We found
excellent colocalization of the EGFP and ChAT signals in the
neurons and neuronal processes in septal BFCN. In contrast,
the fluorescent EGFP-expressing cells in the hippocampus
showed minimal, or no ChAT staining, and their processes were
devoid of the ChAT signal even though most of the processes
in this region showed colocalization of ChAT and EGFP,
indicating that our immunostaining has adequate sensitivity
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FIGURE 1 | Intrinsic EGFP fluorescence and choline acetyltransferase (ChAT) immunofluorescence (Millipore AB144P; 1:200) in brain sections of the
21 days old ChAT-EGFP mice visualized with confocal microscopy. Note, strong ChAT staining and colocalization of the EGFP and ChAT signal (red) in the
septal cell bodies and fibers (top panels). In contrast, the hippocampus (bottom panels) shows minimal (arrows) or no ChAT cell body staining and the colocalization
of the EGFP and ChAT signals is seen only in fibers that do not emanate from the hippocampal cell bodies (presumably the septohippocampal afferents). The fibers
of the EGFP-expressing cells do not show ChAT-immunostaining (arrow heads). Original magnifications: 10× (top panels) and 20× (lower panels). All procedures
were performed in accordance with the protocol approved by the Boston University IACUC.
for the detection of ChAT even in small structures. The latter
fibers undoubtedly represent the septohippocampal afferents.
In a report published recently, Yi et al. (2015) examined the
electrophysiological and molecular phenotypes of fluorescent
hippocampal cells using Chat-EGFP and Chat-Cre (crossed
with Rosa26EYFP mice to generate EYFP-expressing cells)
mouse lines; see also the associated editorial by Vijayaraghavan
and Sharma (2015). They appropriately used quotation marks
when referring to these cells as ‘‘cholinergic neurons’’ because
while the cells exhibited the reporter protein expression, they
did not stain for ChAT, indicating that they did not produce
ACh. Moreover, the authors were unable to show ACh release
from these cells. Instead these ‘‘cholinergic neurons’’ released
glutamate upon depolarization and thus must be considered
as glutamatergic. We conclude that the data reported by Yi
et al. (2015), together with our observations (Figure 1), indicate
that the adult hippocampus is devoid of intrinsic cholinergic
neurons, consistent with the studies cited above. Whether such
neurons occur early in development remains to be determined.
If they do however, one would expect a relatively high number
of EYFP-expressing hippocampal cells to arise from the Cre-
mediated recombination in the Chat-Cre× Rosa26EYFP crosses
performed by Yi et al. (2015). This, however was not observed,
indicating that inappropriate activity of the Chat-BAC promoter
constitutes a rare event in these mice, as acknowledged by
Yi et al. (2015). The ectopic expression of the promoter may
suggest that the BACs used for the generation of these mice
are too short and do not contain all of the cis-DNA segments
necessary for the appropriate silencing of the cholinergic
gene locus in all non-cholinergic cells, or that the chromatin
elements in the regions of BAC integration within the murine
genome can occasionally override the normal control of the
cholinergic gene locus. We note that the Chat-BAC mouse
lines frequently harbor multiple copies of the BAC and that,
to date, no studies on the integration sites of any of these
BACs have been reported. Some of the drawbacks of the
BAC-mediated transgenesis can be obviated by a knock-in
strategy to produce comparable transgenic mice. Successful
examples of this approach are lines in which a Cre allele, that
is expressed via an internal ribosome entry site, was inserted
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downstream of the stop codon of the endogenous Chat gene
as described by Rotolo et al. (2008) and Rossi et al. (2011).
The former line has been used to investigate hippocampal
cholinergic innervation. Consistent with the results of studies
obtained with immunohistochemical methods, no intrinsic
hippocampal cholinergic cells have been reported in these mice
(Wu et al., 2014). In sum, the experience of the studies of
Chat-BAC transgenic mice indicates that they are an excellent
tool for the determination of the properties and physiological
functions of bona fide cholinergic neurons in health and
disease. However, their use to discover novel populations of
cholinergic cells requires caution and rigor. If the only evidence
for a new class of cholinergic neurons is the expression of
a reporter protein in a Chat-BAC mouse line, it is best to
conclude that such a class does not exist. Because there are
now many BAC transgenic lines available to investigators,
we posit that similar considerations should be applied
to those.
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